MCK
Neutral signalScored 2026-10-20 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
Research, not advice.
À propos
McKesson Corporation
- Nom
- McKesson Corporation
- Secteur
- Healthcare
- Industrie
- Medical - Distribution
- Bourse
- NYSE
- Capitalisation
- $116.4B
- Employés
- 42,300
- PDG
- Brian S. Tyler
- Site web
- https://www.mckesson.com
- Marché
- ACHCAHCORSHPMYSHTDYSIG.AX
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 8 764 titres (~6 984 488,10 $ US)
- Insiders
- Lerman Bradley ETYLER BRIAN S.
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$1,164,670
Avg sell (VWAP, 90d window) $960.56 vs last close $992.87 (+3.4%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$98,951 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-08-10
- Liquidity
- Liquid $701,327,972/day · 20d vol
- Last synced
-
2026-10-27 09:40:42
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-10-15 | Fraga Francisco | Sell · S | 800 | $995.80 | $797,129 | Form 4 |
| 2026-09-08 | Rutledge Napoleon B JR | Sell · S · 10b5-1 | 111 | $891.45 | $98,951 | Form 4 |
| 2026-08-10 | Lerman Bradley E | Sell · S | 301 | $892.33 | $268,590 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
| Date | Member | Side | Amount range | Filing |
|---|---|---|---|---|
| 2026-09-04 | Ro Khanna | Buy | $1,001 - $15,000 | Filing |
| 2026-08-10 | Ro Khanna | Buy | $1,001 - $15,000 | Filing |
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-09-04 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-08-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-07-08 | Richard Ray Larsen | Purchase | $1,001 - $15,000 |
| 2026-06-15 | Jonathan Jackson | Sale (Full) | $1,001 - $15,000 |
| 2026-04-08 | Elizabeth Pannill Fletcher | Sale | $1,001 - $15,000 |
| 2025-12-19 | Gilbert Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2025-12-02 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-12-02 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-11-18 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-10-10 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-10-08 | Jonathan Jackson | Sale (Full) | $1,001 - $15,000 |
| 2025-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-09-23 | Val Hoyle | Sale (Full) | $1,001 - $15,000 |
| 2025-09-10 | Val Hoyle | Purchase | $1,001 - $15,000 |
| 2025-08-05 | Gilbert Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2025-07-11 | Ritchie Torres | Sale (Full) | $1,001 - $15,000 |
| 2025-05-12 | Jefferson Shreve | Sale (Full) | $15,001 - $50,000 |
| 2025-04-29 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2025-04-23 | Jonathan Jackson | Purchase | $1,001 - $15,000 |
| 2025-04-09 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2025-03-24 | Jonathan Jackson | Purchase | $1,001 - $15,000 |
| 2025-03-04 | Jonathan Jackson | Purchase | $1,001 - $15,000 |
| 2025-03-03 | Jonathan Jackson | Purchase | $1,001 - $15,000 |
| 2025-01-24 | Gilbert Cisneros | Sale (Full) | $1,001 - $15,000 |
| 2025-01-15 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-01-15 | Jared Moskowitz | Purchase | $1,001 - $15,000 |
| 2025-01-07 | Ritchie Torres | Purchase | $1,001 - $15,000 |
| 2024-12-18 | Julia Letlow | Purchase | $1,001 - $15,000 |
| 2024-09-12 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-07-01 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2024-04-04 | Earl Blumenauer | Sale (Partial) | $15,001 - $50,000 |
| 2024-03-20 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-11-16 | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 2023-09-08 | Lois Frankel | Sale (Full) | $1,001 - $15,000 |
| 2023-08-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-07-18 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-06-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-26 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-06-08 | William R. Keating | Purchase | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-05-19 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-03-14 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-03-06 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-02-23 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-02-14 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-02-10 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-01-31 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2023-01-11 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-11-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-10-21 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-10-21 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-10-21 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-08-03 | Kathy E. Manning | Sale (Full) | $1,001 - $15,000 |
| 2022-07-20 | Kathy E. Manning | Purchase | $1,001 - $15,000 |
| 2022-06-21 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-06-21 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-06-21 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-05-20 | Diana Harshbarger | Purchase | $1,001 - $15,000 |
| 2022-03-14 | Earl Blumenauer | Sale (Full) | $1,001 - $15,000 |
| 2022-03-09 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2022-03-08 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2022-03-02 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2022-02-24 | Earl Blumenauer | Purchase | $1,001 - $15,000 |
| 2022-02-07 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2022-01-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-01-20 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2021-10-28 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2021-09-02 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2021-03-23 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2020-11-13 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2020-04-08 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2019-09-25 | Lois Frankel | Purchase | $1,001 - $15,000 |
| 2019-09-24 | Lois Frankel | Sale (Full) | $1,001 - $15,000 |
| 2019-05-13 | Dean Phillips | Purchase | $1,001 - $15,000 |
| 2019-04-05 | Earl Blumenauer | Purchase | $1,001 - $15,000 |
| 2019-03-25 | Bill Flores | Purchase | $1,001 - $15,000 |
| 2019-03-14 | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 2019-01-04 | Dean Phillips | Purchase | $1,001 - $15,000 |
| 2018-12-24 | Lois Frankel | Sale (Partial) | $1,001 - $15,000 |
| 2018-06-14 | Earl Blumenauer | Purchase | $1,001 - $15,000 |
| 2017-04-04 | Gary James Palmer | Purchase | $1,001 - $15,000 |
Signal
Neutral signalScored 2026-10-20 Drivers: Congress, trend, fundamentals. Moteurs : Congrès, tendance, fondamentaux.
MCK shows solid operational fundamentals with expanding margins and strong debt coverage, but a weak catalyst score (35) with no identifiable near-term event driver limits upside conviction.
The first sentence of the analysis written for MCK on 2026-10-20 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Congress Pulls against a bullish reading. STOCK Act sale disclosures outnumber purchases
- Timing Supports a bullish reading. Interesting trend — weekly bias up
- Financial indicators Pulls against a bullish reading. Current ratio 0.85 · operating margin 1.6%
Suggested stop 871.62, nearest stored support minus 0.5 ATR(12.2% under the last close). Reward/risk to the next stored resistance is 0.07. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Recent news
- 2026-10-19 McKesson Corporation $MCK Shares Purchased by IFP Advisors Inc IFP Advisors Inc lifted its position in McKesson Corporation (NYSE: MCK) by 10.7% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,514 shares of the company''s stock after purchasing an additional 728 shares during the period. IFP
- 2026-10-18 Counterpoint Mutual Funds LLC Buys 1,788 Shares of McKesson Corporation $MCK Counterpoint Mutual Funds LLC boosted its stake in shares of McKesson Corporation (NYSE: MCK) by 18.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,235 shares of the company''s stock after purchasing an additional 1,788 shares during the quarter. McKesson comprises 0.8%
- 2026-10-18 McKesson Corporation $MCK Stock: Aspiriant LLC Grows Holdings Aspiriant LLC increased its holdings in shares of McKesson Corporation (NYSE: MCK) by 201.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,402 shares of the company''s stock after acquiring an additional 937 shares during the quarter. Aspiriant LLC''s holdings
- 2026-10-15 Jim Cramer: This Health Care Stock Is A ‘Winner'', X-Energy Is ‘Losing Too Much Money'' On CNBC''s “Mad Money Lightning Round,” Jim Cramer said McKesson Corporation (NYSE:MCK) is a “winner” and it will go much higher. “It is exactly what you buy in this environment," he added.
- 2026-10-15 691 Shares in McKesson Corporation $MCK Bought by Sax Wealth Advisors LLC Sax Wealth Advisors LLC purchased a new position in McKesson Corporation (NYSE: MCK) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 691 shares of the company''s stock, valued at approximately $590,000. A number of other institutional investors and
- 2026-10-15 McKesson Corporation $MCK Stock: First Citizens Bank & Trust Co. Increases Stake First Citizens Bank and Trust Co. grew its stake in McKesson Corporation (NYSE: MCK) by 95.9% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,830 shares of the company''s stock after purchasing an additional 2,365 shares during the period. First
- 2026-10-14 McKesson (MCK) Ascends While Market Falls: Some Facts to Note McKesson (MCK) reached $976.57 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.
- 2026-10-13 McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy? Whether you''re a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 2026-10-13 McKesson Corporation $MCK Stock Acquired by Terra Nova Asset Management LLC Terra Nova Asset Management LLC increased its stake in shares of McKesson Corporation (NYSE: MCK) by 31.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,995 shares of the company''s stock after buying an additional 720 shares during the quarter.
- 2026-10-13 Vertrix Wealth Management LLC Sells 593 Shares of McKesson Corporation $MCK Vertrix Wealth Management LLC lessened its position in McKesson Corporation (NYSE: MCK) by 10.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,179 shares of the company''s stock after selling 593 shares during the quarter. McKesson makes up about
Market snapshot
Financial ratios
| Metric | Trend | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 3.6% | 3.5% | 3.9% | 4.3% | 4.8% | |
| Ebit Margin | 1.6% | 1.3% | 1.3% | 1.8% | 0.8% | |
| Ebitda Margin | 1.8% | 1.5% | 1.5% | 2.0% | 1.1% | |
| Operating Profit Margin | 1.6% | 1.2% | 1.3% | 1.6% | 1.0% | |
| Pretax Profit Margin | 1.5% | 1.2% | 1.2% | 1.7% | 0.7% | |
| Continuous Operations Profit Margin | 1.3% | 1.0% | 1.0% | 1.3% | 0.5% | |
| Net Profit Margin | 1.2% | 0.9% | 1.0% | 1.3% | 0.4% | |
| Bottom Line Profit Margin | 1.2% | 0.9% | 1.0% | 1.3% | 0.4% | |
| Current Ratio | 0.854 | 0.899 | 0.916 | 0.924 | 0.954 | |
| Quick Ratio | 0.492 | 0.526 | 0.512 | 0.513 | 0.568 | |
| Solvency Ratio | 0.066 | 0.051 | 0.053 | 0.065 | 0.029 | |
| Cash Ratio | 0.059 | 0.092 | 0.088 | 0.098 | 0.073 | |
| Price To Earnings Ratio | 22.448 | 26.024 | 23.802 | 14.112 | 41.878 | |
| Price To Earnings Growth Ratio | 0.457 | 1.767 | -2.232 | 0.058 | -0.330 | |
| Forward Price To Earnings Growth Ratio | 0.457 | 1.767 | -2.232 | 0.058 | -0.330 | |
| Price To Earnings Diluted Ratio | 22.547 | 26.166 | 23.961 | 14.219 | 42.342 | |
| Price To Earnings Diluted Growth Ratio | 0.458 | 1.759 | -2.264 | 0.058 | -0.334 | |
| Price To Book Ratio | -49.244 | -41.340 | -36.256 | -27.054 | -20.521 | |
| Price To Sales Ratio | 0.265 | 0.239 | 0.231 | 0.182 | 0.177 | |
| Price To Free Cash Flow Ratio | 19.771 | 16.406 | 19.702 | 10.919 | 11.958 | |
| Price To Operating Cash Flow Ratio | 17.377 | 14.090 | 16.565 | 9.738 | 10.515 | |
| Debt To Assets Ratio | 0.105 | 0.098 | 0.110 | 0.117 | 0.119 | |
| Debt To Equity Ratio | -3.966 | -3.563 | -3.749 | -3.928 | -3.320 | |
| Debt To Capital Ratio | 1.337 | 1.390 | 1.364 | 1.341 | 1.431 | |
| Long Term Debt To Capital Ratio | 1.740 | 1.868 | 1.546 | 1.671 | 1.809 | |
| Financial Leverage Ratio | -37.902 | -36.230 | -34.218 | -33.560 | -27.860 | |
| Working Capital Turnover Ratio | -50.388 | -67.790 | -76.739 | -93.800 | -552.230 | |
| Operating Cash Flow Ratio | 0.092 | 0.099 | 0.082 | 0.108 | 0.091 | |
| Operating Cash Flow Sales Ratio | 0.015 | 0.017 | 0.014 | 0.019 | 0.017 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.879 | 0.859 | 0.841 | 0.892 | 0.879 | |
| Debt Service Coverage Ratio | 4.013 | 3.022 | 13.782 | 3.767 | 2.282 | |
| Interest Coverage Ratio | 26.130 | 17.078 | 16.160 | 17.956 | 15.298 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.858 | 5.109 | 86.280 | 5.330 | 5.549 | |
| Operating Cash Flow Coverage Ratio | 0.715 | 0.823 | 0.584 | 0.707 | 0.588 | |
| Capital Expenditure Coverage Ratio | 8.262 | 7.084 | 6.279 | 9.246 | 8.288 | |
| Dividend Paid And Capex Coverage Ratio | 5.466 | 5.054 | 4.310 | 6.069 | 5.461 | |
| Dividend Payout Ratio | 0.080 | 0.105 | 0.105 | 0.082 | 0.249 | |
| Enterprise Value Multiple | 15.549 | 16.652 | 15.913 | 9.635 | 17.667 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 3.6% | ▲0.1% | ▼-0.4% |
| Ebit Margin | 1.6% | ▲0.3% | ▲0.2% |
| Ebitda Margin | 1.8% | ▲0.3% | ▲0.2% |
| Operating Profit Margin | 1.6% | ▲0.4% | ▲0.2% |
| Pretax Profit Margin | 1.5% | ▲0.3% | ▲0.3% |
| Continuous Operations Profit Margin | 1.3% | ▲0.3% | ▲0.2% |
| Net Profit Margin | 1.2% | ▲0.3% | ▲0.2% |
| Bottom Line Profit Margin | 1.2% | ▲0.3% | ▲0.2% |
| Current Ratio | 0.854 | ▼-0.046 | ▼-0.056 |
| Quick Ratio | 0.492 | ▼-0.033 | ▼-0.030 |
| Solvency Ratio | 0.066 | ▲0.015 | ▲0.013 |
| Cash Ratio | 0.059 | ▼-0.033 | ▼-0.023 |
| Price To Earnings Ratio | 22.448 | ▼-3.577 | ▼-3.205 |
| Price To Earnings Growth Ratio | 0.457 | ▼-1.309 | ▲0.513 |
| Forward Price To Earnings Growth Ratio | 0.457 | ▼-1.309 | ▲0.513 |
| Price To Earnings Diluted Ratio | 22.547 | ▼-3.619 | ▼-3.300 |
| Price To Earnings Diluted Growth Ratio | 0.458 | ▼-1.301 | ▲0.523 |
| Price To Book Ratio | -49.244 | ▼-7.904 | ▼-14.361 |
| Price To Sales Ratio | 0.265 | ▲0.026 | ▲0.046 |
| Price To Free Cash Flow Ratio | 19.770 | ▲3.364 | ▲4.019 |
| Price To Operating Cash Flow Ratio | 17.378 | ▲3.287 | ▲3.720 |
| Debt To Assets Ratio | 0.105 | ▲0.006 | ▼-0.005 |
| Debt To Equity Ratio | -3.966 | ▼-0.403 | ▼-0.261 |
| Debt To Capital Ratio | 1.337 | ▼-0.053 | ▼-0.036 |
| Long Term Debt To Capital Ratio | 1.740 | ▼-0.128 | ▲0.013 |
| Financial Leverage Ratio | -37.902 | ▼-1.672 | ▼-3.948 |
| Working Capital Turnover Ratio | -50.388 | ▲17.402 | ▲117.802 |
| Operating Cash Flow Ratio | 0.092 | ▼-0.007 | ▼-0.003 |
| Operating Cash Flow Sales Ratio | 0.015 | ▼-0.002 | ▼-0.001 |
| Free Cash Flow Operating Cash Flow Ratio | 0.879 | ▲0.020 | ▲0.009 |
| Debt Service Coverage Ratio | 4.013 | ▲0.990 | ▼-1.361 |
| Interest Coverage Ratio | 26.130 | ▲9.051 | ▲7.605 |
| Short Term Operating Cash Flow Coverage Ratio | 4.858 | ▼-0.251 | ▼-16.567 |
| Operating Cash Flow Coverage Ratio | 0.715 | ▼-0.109 | ▲0.031 |
| Capital Expenditure Coverage Ratio | 8.262 | ▲1.178 | ▲0.430 |
| Dividend Paid And Capex Coverage Ratio | 5.466 | ▲0.412 | ▲0.194 |
| Dividend Payout Ratio | 0.080 | ▼-0.025 | ▼-0.044 |
| Enterprise Value Multiple | 15.549 | ▼-1.102 | ▲0.466 |
Key metrics
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| Market cap | $106.96B | $85.74B | $71.46B | $50.24B | $46.62B | |
| Enterprise value | $111.60B | $87.44B | $74.27B | $52.86B | $50.63B | |
| EV / Sales | 0.28x | 0.24x | 0.24x | 0.19x | 0.19x | |
| EV / Op. cash flow | 18.13x | 14.37x | 17.21x | 10.24x | 11.42x | |
| EV / Free cash flow | 20.63x | 16.73x | 20.48x | 11.49x | 12.99x | |
| EV / EBITDA | 15.55x | 16.65x | 15.91x | 9.63x | 17.67x | |
| Net debt / EBITDA | 0.65x | 0.32x | 0.60x | 0.48x | 1.40x | |
| Current ratio | 0.85x | 0.90x | 0.92x | 0.92x | 0.95x | |
| Income quality | 1.29x | 1.75x | 1.36x | 1.39x | 3.44x | |
| Graham net-net | -$373 | -$317 | -$283 | -$246 | -$251 | |
| Tax burden | 76.8% | 75.6% | 79.2% | 76.9% | 57.8% | |
| Interest burden | 96.2% | 94.5% | 94.0% | 94.9% | 91.5% | |
| Working capital | -$9.81B | -$6.21B | -$4.39B | -$3.67B | -$2.23B | |
| Invested capital | $10.31B | $9.56B | $11.90B | $12.37B | $12.91B | |
| Return on assets | 5.8% | 4.4% | 4.5% | 5.7% | 1.8% | |
| Operating ROA | 8.2% | 6.1% | 6.1% | 7.1% | 4.2% | |
| Return on tangible assets | 7.1% | 5.2% | 5.4% | 7.1% | 2.2% | |
| Return on equity | -219.2% | -158.9% | -152.3% | -191.7% | -49.0% | |
| Return on invested capital | 31.5% | 23.3% | 21.2% | 22.9% | 11.5% | |
| Return on capital employed | 42.2% | 32.3% | 26.0% | 31.0% | 18.4% | |
| Earnings yield | 4.5% | 3.8% | 4.2% | 7.1% | 2.4% | |
| Free cash flow yield | 5.1% | 6.1% | 5.1% | 9.2% | 8.4% | |
| Capex / Op. cash flow | 12.1% | 14.1% | 15.9% | 10.8% | 12.1% | |
| Capex / Depreciation | 102.2% | 135.1% | 108.2% | 91.8% | 70.4% | |
| Capex / Sales | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | |
| SG&A / Sales | -2.0% | 2.2% | 2.7% | 2.6% | 3.7% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | |
| Intangibles / Total assets | 18.7% | 15.3% | 18.2% | 19.6% | 18.2% | |
| Days sales outstanding | 25d | 26d | 26d | 26d | 26d | |
| Days payables outstanding | 56d | 58d | 58d | 59d | 55d | |
| Operating cycle | 48d | 50d | 52d | 53d | 53d | |
| Cash conversion cycle | -8d | -8d | -6d | -6d | -2d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years